In the INAVO120 study, Itovebi—used in combination with Pfizer’s Ibrance and AstraZeneca’s Faslodex—delivered a statistically significant and clinically meaningful overall survival benefit ...
Getting a plum government gig in Russia is a lot easier if you’ve served in the Kremlin’s presidential bodyguard agency, the Federal Protection Service (bonus points if you’ve saved Vladimir ...
Pfizer is to make its breast cancer drug Ibrance (palbociclib) available for free to NHS patients while it waits for a final decision on the drug’s cost-effectiveness. The drug has been hailed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback